Patents by Inventor Joseph Daniel HO

Joseph Daniel HO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLUCAGON-LIKE PEPTIDE1 RECEPTOR AGONISTS
    Publication number: 20230250092
    Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
    Type: Application
    Filed: March 31, 2023
    Publication date: August 10, 2023
    Inventors: David Andrew COATES, Todd FIELDS, Joseph Daniel HO, Fucheng QU
  • Glucagon-like peptide1 receptor agonists
    Patent number: 11655242
    Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: May 23, 2023
    Assignee: Eli Lilly and Company
    Inventors: David Andrew Coates, Todd Fields, Joseph Daniel Ho, Fucheng Qu
  • GLUCAGON-LIKE PEPTIDE1 RECEPTOR AGONISTS
    Publication number: 20200407347
    Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
    Type: Application
    Filed: June 19, 2020
    Publication date: December 31, 2020
    Inventors: David Andrew COATES, Todd FIELDS, Joseph Daniel HO, Fucheng QU